Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent
Paliperidone palmitate three-month injection (Invega Trinza): the first four-times-a-year, long-acting injectable antipsychotic agent for schizophrenia.
Saved in:
| Published in | P&T (Lawrenceville, N.J.) Vol. 41; no. 4; pp. 222 - 227 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
United States
MediMedia USA, Inc
01.04.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Summary: | Paliperidone palmitate three-month injection (Invega Trinza): the first four-times-a-year, long-acting injectable antipsychotic agent for schizophrenia. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Dr. Daghistani is a Resident in Psychiatric Pharmacy Practice at Nova Southeastern University, College of Pharmacy, in Fort Lauderdale, Florida. Dr. Rey is Associate Professor of Pharmacy Practice at the same institution. Drug Forecast is a regular column coordinated by Alan Caspi, PhD, PharmD, President of Caspi & Associates in New York, New York. |
| ISSN: | 1052-1372 |